NASDAQ$MIST

Milestone Pharmaceuticals Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Headline financials

EPS (adj)

-$0.40

Previous: -$0.52+23.1%

Revenue & EPS history

Milestone Pharmaceuticals · Revenue · Quarterly

$238K

Q1 2026
Beat estimate in 1 of 3 quarters(33%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

+1.7%

Avg return

Earnings day

-0.2%

Avg return

5 days after

+2.2%

Avg return

30 days after

64%

18 / 28 earnings

Positive

+24.1%

Q3 2021

Best reaction

-23.0%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-9.5%-23.2%
Q4 2026-20.0%-26.5%+23.5%
Q3 2025+1.0%+21.5%+26.2%
Q2 2025+7.1%+9.7%+23.2%
Q1 2025-1.7%+8.4%+38.7%
Q4 2024+7.9%-53.7%-38.9%
Q3 2024-5.2%-12.4%-4.1%
Q1 2024+1.2%+2.4%-16.5%
Q4 2023+16.0%+20.7%+9.3%
Q3 2023-23.0%-24.4%-13.7%
Q2 2023+1.6%+2.6%-7.1%
Q1 2023+12.8%+0.5%+1.3%
Q4 2022-4.0%-0.3%-9.0%
Q3 2022+13.0%+7.1%-0.7%
Q2 2022+3.6%+5.3%+29.2%
Q1 2022-2.5%+1.6%+1.6%
Q4 2021+12.4%+17.5%+22.0%
Q3 2021+24.1%+13.9%+4.5%
Q2 2021+0.2%+2.1%+7.1%
Q1 2021+0.5%+1.3%+6.1%
Q4 2020-6.6%-2.4%-4.0%
Q3 2020+6.1%+6.0%+19.8%
Q2 2020-1.8%+0.3%-12.2%
Q1 2020+0.3%+4.8%+29.5%
Q4 2019+7.4%+8.7%-90.4%
Q3 2019-4.2%-1.2%-7.2%
Q2 2019+7.8%+9.9%+38.1%
Q1 2019+3.4%-4.5%-16.2%
Q4 2018
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro